Mangoceuticals (MGRX) Accumulated Expenses (2023 - 2025)
Historic Accumulated Expenses for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $4460.0.
- Mangoceuticals' Accumulated Expenses fell 2007.17% to $4460.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4460.0, marking a year-over-year decrease of 2007.17%. This contributed to the annual value of $6595.0 for FY2023, which is N/A changed from last year.
- As of Q3 2025, Mangoceuticals' Accumulated Expenses stood at $4460.0, which was down 2007.17% from $2973.0 recorded in Q2 2025.
- In the past 5 years, Mangoceuticals' Accumulated Expenses ranged from a high of $8203.0 in Q1 2024 and a low of $2973.0 during Q2 2025
- Over the past 3 years, Mangoceuticals' median Accumulated Expenses value was $5852.5 (recorded in 2023), while the average stood at $5852.9.
- Within the past 5 years, the most significant YoY rise in Mangoceuticals' Accumulated Expenses was 2007.17% (2025), while the steepest drop was 3656.92% (2025).
- Quarter analysis of 3 years shows Mangoceuticals' Accumulated Expenses stood at $6595.0 in 2023, then dropped by 15.39% to $5580.0 in 2024, then decreased by 20.07% to $4460.0 in 2025.
- Its last three reported values are $4460.0 in Q3 2025, $2973.0 for Q2 2025, and $5580.0 during Q3 2024.